If the new data is added to the label of Jardiance (empagliflozin), the SGLT2 inhibitor would become the first in the class to be approved to treat all types of chronic heart failure as well as ...

Dapagliflozin and empagliflozin cut mortality from heart failure with reduced ejection fraction whether or not patients have ...

Boehringer and Lilly are also running another pair of trials, called EMPERIAL, which are investigating the possible benefits of Jardiance on exercise capacity and heart failure symptoms and are ...

Jardiance (empagliflozin ... Even though there isn't a cure yet, many people can live fulfilling lives with heart failure if they manage it well. According to some research, people with CHF ...

Opens in a new tab or window Use of empagliflozin ... to advanced disease." However, in an accompanying commentary, Jonathan E. Shaw, MD, and Alicia J. Jenkins, MD, of Baker Heart and Diabetes ...

Lupin strengthens diabetes portfolio with acquisition of Gibtulio, Gibtulio Met, and Ajaduo trademarks from Boehringer ...

On Your Side and Nina Pineda help a stage 4 cancer survivor who was denied life-saving medication by her health insurance company.

After trying several expensive medications my doctor prescribed for dandruff and rosacea, I stumbled on a face cleanser that ...

An estimated 80 million people above the age of 18 years have diabetes in India, in addition to 25 million 2 that are pre-diabetic.

"To our knowledge, this is the first study to evaluate diabetic retinopathy progression using data generated from clinical ...

NEW ORLEANS -- Patients at a community health center who had type 2 diabetes and a high risk of atherosclerotic ...